ENSC
Ensysce Biosciences, Inc.Company with tickers: ENSC, ENSCW
CIK
1716947
CUSIP
293602504
Shares Outstanding
14,694,492
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $960,999 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $4,523,229 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $3,346,881 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-3,562,230 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | — | ||||
| EPS (Basic) | $-0.52 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-0.52 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |